Cleared Traditional

K180064 - OsteoFab Patient Specific Cranial Device

K180064 is the FDA 510(k) clearance for OsteoFab Patient Specific Cranial Device by Oxford Performance Materials, Inc.. It is a Class 2 Neurology device (product code GXN) cleared through the Traditional 510(k) pathway after a 199-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2018
Decision
199d
Days
Class 2
Risk

K180064 is an FDA 510(k) clearance for the OsteoFab Patient Specific Cranial Device. Classified as Plate, Cranioplasty, Preformed, Non-alterable (product code GXN), Class II - Special Controls.

Submitted by Oxford Performance Materials, Inc. (South Windsor, US). The FDA issued a Cleared decision on July 27, 2018 after a review of 199 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5330 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Oxford Performance Materials, Inc. devices

Submission Details

510(k) Number K180064 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 09, 2018
Decision Date July 27, 2018
Days to Decision 199 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d slower than avg
Panel avg: 148d · This submission: 199d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GXN Plate, Cranioplasty, Preformed, Non-alterable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXN Plate, Cranioplasty, Preformed, Non-alterable

All 33
Devices cleared under the same product code (GXN) and FDA review panel - the closest regulatory comparables to K180064.
DePuy Synthes Craniomaxillofacial Neuro Devices - MR Conditional
K192702 · Synthes USA Products, LLC · Sep 2020
CustomizedBone Service
K193547 · Fin-Ceramica Faenza S.P.A. · Jan 2020
Longeviti ClearFit Cranial Implant
K191210 · Longeviti Neuro Solutions, LLC · Jan 2020
CustomizedBone Service
K180513 · Fin-Ceramica Faenza S.P.A. · May 2018
Longeviti PMMA Static Cranial Implant
K170410 · Longeviti Neuro Solutions, LLC · Mar 2018
Patient Contoured Implant-PEEK (PCI-PEEK)
K151382 · KLS-Martin L.P. · Nov 2015